NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols
Linda Zuurbier(Amsterdam Neuroscience), Jules P.P. Meijerink(Erasmus MC - Sophia Children’s Hospital), Clarissa Kooi(Erasmus MC), Rob Pieters(Princess Máxima Center), Edwin Sonneveld(Princess Máxima Center), Willem K. Smits(Princess Máxima Center), Jessica G. C. A. M. Buijs-Gladdines(Princess Máxima Center), Irene Homminga(Erasmus MC), Martin A. Horstmann(Universität Hamburg), Willem A. Kamps(Pediatric Oncology Group), ML te Winkel(Erasmus MC), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Valerie Calvert(George Mason University)
Cited by 141
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
|New England Journal of Medicine|2004|645